From: DoMINO: Donor milk for improved neurodevelopmental outcomes
Component | Effect | References |
---|---|---|
Adiponectin | 33% reduction | [43] |
Amylase | 15% loss of activity | [44] |
B-cells, T-cells | Abolished | |
Bile salt dependent lipase | Abolished | [44] |
CD14 (soluble) | 88% reduction | [47] |
Fats: | Â | Â |
 Total fat | No effect | |
 C14:1-C24:1 | No effect | |
 C8:0-C24:0 | No effect | |
 n-3,n-6 PUFA | No effect | |
 AA, DHA | No effect | |
 Linoleic, linolenic | Reduced | [51] |
Calcium | No effect | [48] |
Copper | 9% reduction No effect | |
Escherichia coli inhibition | 26% reduction | [53] |
Epidermal growth factor | No effect | |
Erythropoeitin | Significantly reduced | [56] |
Folate | 16-31% reduction | |
Free fatty acids | 80% increase | [57] |
Gangliosides | No effect | [54] |
Hepatocyte growth factor | 60% reduction | [54] |
Immunoglobulins: | Â | Â |
 IgA, sIgA | 0-48% reduction | |
 IgG | 34% reduction | [60] |
 IgM | Abolished | |
Insulin | 46% reduction | [43] |
IGF-1, IGF-2, IGF-BP2,3 | 7-39% reduction | [55] |
IL-1β, IL-10 | Significantly reduced | |
IL-2, Il-4, IL-5, IL-12, IL-13 | No effect | [54] |
IL-8 | Increased | [54] |
Interferon gamma | Significantly reduced | [54] |
Iron | 0-15% reduction | |
Lactate | 7% reduction | [57] |
Lactoferrin | 57-80% reduction | |
Lactose | No effect | |
Lipoprotein lipase | Abolished | [44] |
Lysine | Significantly reduced | |
Lysozyme activity | No effect 24-60% reduction | |
Lymphocytes | Abolished | [46] |
Magnesium | No effect | [48] |
Mannose-binding lectin | No effect | [47] |
Oligosaccharides | No effect | [64] |
Phosphorus | No effect | [48] |
Potassium | No effect | [48] |
Protein | No effect Reduced | |
Sodium | No effect | |
TGF-α, TGF-β | No effect Reduced | |
Vitamin A | No effect | [50] |
Vitamin B6 | 15% reduction | [42] |
Vitamin C | 36% reduction | [42] |
Zinc | 0-3% reduction |